Fishman Jay A LTD Bicycle Therapeutics PLC Transaction History

Fishman Jay A LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$16.75 - $26.1 $427,125 - $665,550	-25,500 Reduced 73.91%	9,000 $224,000
Q4 2023 Jan 24, 2024	SELL	$13.29 - $22.2 $39,870 - $66,600	-3,000 Reduced 8.0%	34,500 $623,000
Q3 2023 Nov 13, 2023	BUY	$19.9 - $26.25 $338,300 - $446,250	17,000 Added 82.93%	37,500 $753,000
Q2 2023 Aug 15, 2023	BUY	$18.95 - $28.67 $189,500 - $286,700	10,000 Added 95.24%	20,500 $523,000
Q4 2022 Feb 13, 2023	BUY	$20.37 - $32.9 $213,885 - $345,450	10,500 New	10,500 $310,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

Stay updated on Fishman Jay A LTD with notifications on news.